SCOPUS 정보 검색 플랫폼

Journal of Clinical Oncology

Volumn 28, Issue 20, 2010, Pages

Absolute benefits of aromatase inhibitors in adjuvant treatment of breast cancer: Should we know more?

(4) Seruga, Bostjan a Ocana, Alberto a Niraula, Saroj a Amir, Eitan a

a UNIVERSITY OF TORONTO (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; AROMATASE INHIBITOR; ESTROGEN RECEPTOR; HORMONE; TAMOXIFEN; ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RECURRENCE; FOLLOW UP; HEALTH CARE PERSONNEL; HUMAN; LETTER; OVERALL SURVIVAL; POSTMENOPAUSE; PRIORITY JOURNAL; RECURRENCE RISK; RISK REDUCTION; ADJUVANT CHEMOTHERAPY; BREAST TUMOR; FEMALE; META ANALYSIS; METHODOLOGY; MORTALITY; NOTE;

ANTINEOPLASTIC AGENTS; AROMATASE INHIBITORS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; META-ANALYSIS AS TOPIC; RESEARCH DESIGN;

EID: 77954738637 PISSN: 0732183X EISSN: 15277755 Source Type: Journal
DOI: 10.1200/JCO.2010.28.3564 Document Type: Letter

Times cited : (5)

References (6)

1
- 75749092296
- Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen
- Dowsett M, Cuzick J, Ingle J, et al: Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen. J Clin Oncol 28:509-918, 2010
- (2010) J Clin Oncol , vol.28 , pp. 509-918
- Dowsett, M.¹ Cuzick, J.² Ingle, J.³

2
- 60849104442
- Up-front use of aromatase inhibitors as adjuvant therapy for breast cancer: The emperor has no clothes
- Seruga B, Tannock IF: Up-front use of aromatase inhibitors as adjuvant therapy for breast cancer: The emperor has no clothes. J Clin Oncol 27:840-842, 2009
- (2009) J Clin Oncol , vol.27 , pp. 840-842
- Seruga, B.¹ Tannock, I.F.²

3
- 69049113989
- Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer
- BIG 1-98 Collaborative Group
- BIG 1-98 Collaborative Group: Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer. N Engl J Med 361:766-776, 2009
- (2009) N Engl J Med , vol.361 , pp. 766-776

4
- 0642307268
- Adjuvant chemotherapy for breast cancer: How presentation of recurrence risk influences decision-making
- DOI 10.1200/JCO.2003.06.025
- Chao C, Studts JL, Abell T, et al: Adjuvant chemotherapy for breast cancer: How presentation of recurrence risk influences decision-making. J Clin Oncol 21:4299-4305, 2003 (Pubitemid 46621805)
- (2003) Journal of Clinical Oncology , vol.21 , Issue.23 , pp. 4299-4305
- Chao, C.¹ Studts, J.L.² Abell, T.³ Hadley, T.⁴ Roetzer, L.⁵ Dineen, S.⁶ Lorenz, D.⁷ YoussefAgha, A.⁸ McMasters, K.M.⁹

5
- 0026491985
- Measured enthusiasm: Does the method of reporting trial results alter perceptions of therapeutic effectiveness?
- Naylor CD, Chen E, Strauss B: Measured enthusiasm: Does the method of reporting trial results alter perceptions of therapeutic effectiveness? Ann Intern Med 117:916-921, 1992
- (1992) Ann Intern Med , vol.117 , pp. 916-921
- Naylor, C.D.¹ Chen, E.² Strauss, B.³

6
- 74049162849
- Progress in tailoring adjuvant endocrine therapy for postmenopausal women with early breast cancer
- Bedard PL, Piccart-Gebhart MJ: Progress in tailoring adjuvant endocrine therapy for postmenopausal women with early breast cancer. Curr Opin Oncol 21:491-498, 2009
- (2009) Curr Opin Oncol , vol.21 , pp. 491-498
- Bedard, P.L.¹ Piccart-Gebhart, M.J.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.